| Value | ₹2,125 Cr |
|---|
BSE filing, NSE: AGARWALEYE. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwals Health Care Ltd: key numbers
- Share price
- ₹511.70
- Market cap
- ₹16,222 Cr
- Revenue (annual)
- ₹2,080 Cr
- Net profit (annual)
- ₹133.2 Cr
- P/E (TTM)
- 109.3×Sector 54.5×
- Promoter holding
- 32.33%-0.01% QoQ
- FII holding
- 49.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwals Health Care Ltd
All →Dr. Agarwals Health Care Employee Stock Options
Dr. Agarwal's Health Care allotted 54,728 equity shares to employees on exercise of ESOP 2022 options. Paid-up capital rose to 31,70,99,111 shares, with no cash consideration stated.
Dr. Agarwals Health Care Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%), network-led growth; India EBITDA margin flat near 28%.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Dr. Agarwals Health Care Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹655 Cr (+31.4% YoY) and PAT ₹57 Cr (+55.8%). H1 FY27 revenue ₹1,269 Cr (+28.7%), PAT ₹112 Cr (+50.1%). Strategy is aggressive facility expansion, with 65 FY27E additions.
Dr. Agarwals Health Care Financial Results
Dr. Agarwal's H1 FY27 revenue rose 28.7% to Rs 1,269 crore; PAT rose 50.1% to Rs 112 crore. Amar Agarwal's executive chairman appointment awaits postal ballot approval.
Dr. Agarwals Health Care Board Meeting Date
Dr. Agarwal's Health Care schedules a board meeting on November 5, 2026 to consider Q2 results. An earnings call follows at 6:30 PM IST that day.
Other financial results announcements
All →Axentra Corp Q2 FY27 Results: Net Profit ₹2.7 Cr, Up 800.0% YoY
Axentra Corp Ltd reported revenue from operations of ₹52.6 Cr (+17433.3% YoY) and net profit of ₹2.7 Cr (+800.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹2.7 Cr · +800.0% YoY
Kalind Q2 FY27 Results: Net Profit ₹23.2 Cr, Up 152.2% YoY
Kalind Ltd reported revenue from operations of ₹88.2 Cr (+390.0% YoY) and net profit of ₹23.2 Cr (+152.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹23.2 Cr · +152.2% YoY
Pearl Global Industries Q2 FY27 Results: Net Profit ₹125.8 Cr, Up 74.7% YoY
Pearl Global Industries Ltd reported revenue from operations of ₹1,802 Cr (+37.2% YoY) and net profit of ₹125.8 Cr (+74.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹125.8 Cr · +74.7% YoY
Latteys Industries Q2 FY27 Results: Net Profit ₹0.9 Cr, Up 50.0% YoY
Latteys Industries Ltd reported revenue from operations of ₹35.3 Cr (+72.2% YoY) and net profit of ₹0.9 Cr (+50.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.9 Cr · +50.0% YoY
Sheetal Universal H1 FY27 Results: Net Profit ₹6.7 Cr, Up 346.7% YoY
Sheetal Universal Ltd reported revenue from operations of ₹124.4 Cr (+158.6% YoY) and net profit of ₹6.7 Cr (+346.7% YoY) for H1 FY27.
- Key figure
- Net profit ₹6.7 Cr · +346.7% YoY
Pacific Industries Q2 FY27 Results: Net Profit ₹1.5 Cr, Up 400.0% YoY
Pacific Industries Ltd's board approved unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Half-year revenue from operations was Rs.12,424.85 Lakhs, with a net profit of Rs.291.23 Lakhs.
- Key figure
- Net profit ₹1.5 Cr · +400.0% YoY